FDA Issues High Risk Warning for Transvaginal Mesh

The U.S. Food and Drug Administration is warning transvaginal mesh products, a mainstay of pelvic organ prolapse repair, carries a high risk for adverse events and as result the mesh will now carry a class III warning. Via MedPage Today. Posted January 4, 2016.

–Alanna McCatty

 


Alanna M.

Alanna M. is a graduate of Pace University.


Did you find this article helpful?


Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments

Latest News

Covid-19: Side Effects of Trump’s Treatments

Covid-19: Side Effects of Trump’s Treatments

President Donald Trump announced (via Twitter, of course) what some considered unthinkable, and others considered inevitable — that he had tested positive for Covid-19. Over the weekend, he received various treatments  — supplements like vitamin D, zinc and melatonin, an experimental antibody combination, an antiviral drug and a powerful anti-inflammatory…

Un-Sheltering Tips for Your Health and Immune System

Un-Sheltering Tips for Your Health and Immune System

As we all emerge from our bubbles of limited contact with others, we are walking straight into the double whammy of flu season and COVID-19 germs. Can your body fight off exposure to the flu and COVID? Your immune system feeds off the basics of life — sleep, movement, food…